New stock news: Jiangsu Hengrui Pharmaceuticals, Foritech, and Jinsheng New Energy have submitted their IPO application materials to the China Securities Regulatory Commission.
Hengrui Medicine, Fosun Pharma, and Jingsheng New Energy plan to list on the Hong Kong stock exchange and have already been accepted for filing by the China Securities Regulatory Commission.
On January 17, the China Securities Regulatory Commission issued the "Table of Domestic Enterprises' Overseas Issuance of Securities and Listing Records (first-time public issuance and full circulation) (as of January 16, 2025)". This week (January 13 to January 17), Jiangsu Hengrui Pharmaceuticals, Fulatek, and Jinsheng New Energy's Hong Kong IPO application materials were accepted by the China Securities Regulatory Commission.
Related Articles
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
